Rachel Yehuda, PhD, Elected to National Academy of Medicine
Rachel Yehuda, PhD, Professor and Vice Chair for Veterans Affairs for the Department of Psychiatry, Professor of Neuroscience, and Director of the Traumatic Stress Studies Division at the Icahn School of Medicine at Mount Sinai, has been elected to the prestigious National Academy of Medicine. A renowned leader in the field of trauma, post-traumatic stress disorder (PTSD), and resilience, Dr. Yehuda also leads the PTSD clinical research program and the Neurochemistry and Neuroendocrinology laboratory at the James J. Peters VA Medical Center.
“Election to the National Academy of Medicine is considered one of the highest honors in health and medicine,” says Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai. “Dr. Yehuda’s election is a distinguished achievement and well-deserved recognition of her leadership and important contributions to uncovering the neurobiology of trauma and post-traumatic stress disorder.”
Dr. Yehuda’s early-career research on cortisol and brain function produced some of the initial findings on the endocrinology and neurochemistry of PTSD, revolutionizing the understanding and treatment of the disorder worldwide. Her initial cortisol findings shaped the trajectory of her career, with subsequent research discoveries involving risk and resilience factors, psychological and biological predictors of treatment response, genetic and epigenetic studies, and the intergenerational transmission of trauma and PTSD.
Her current research interests include PTSD biomarkers, innovative PTSD prevention strategies, and novel approaches to PTSD treatment, including the use of psychedelic medications.
Immediately upon being hired as a new assistant professor at the Icahn School of Medicine at Mount Sinai in 1991, she established a specialized program for Holocaust survivors and their families at The Mount Sinai Hospital. She also established the first clinical PTSD program at the James J. Peters VA Medical Center.
Dr. Yehuda received her PhD in Psychology and Neurochemistry and her MS in Biological Psychiatry from the University of Massachusetts at Amherst. She completed her postdoctoral training in biological psychiatry at Yale Medical School. She is the author of more than 450 published papers, chapters, and books in the field of traumatic stress and the neurobiology of PTSD.
New members to the National Academy of Medicine are elected by current active members through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health. Established in 1970 by the National Academy of Sciences, the National Academy of Medicine, formerly known as the Institute of Medicine, is a national resource that provides independent, objective analysis and advice on health issues.
Dr. Yehuda’s election bring Mount Sinai’s total membership in the prestigious group to 27 present and past faculty members. The distinguished Mount Sinai faculty members whom Dr. Yehuda joins in earning this honor are: • Joseph D. Buxbaum, PhD • Neil S. Calman, MD, MMS • Dennis S. Charney, MD • Kenneth L. Davis, MD • Robert J. Desnick, MD, PhD • Kurt W. Deuschle, MD •Angela Diaz, MD, MPH • Valentin Fuster, MD, PhD • Bruce Gelb, MD • Alison M. Goate, DPhil • E. Cuyler Hammond, DSc • Kurt Hirschhorn, MD • Yasmin L. Hurd, PhD • Philip J. Landrigan, MD, MSc • Helen S. Mayberg, MD • Diane E. Meier, MD • Eric J. Nestler, MD, PhD • Maria Iandolo New, MD • Peter Palese, PhD • Ramon E. Parsons, MD, PhD • Lynn D. Richardson, MD • Hugh A. Sampson, MD • Irving J. Selikoff, MD • Pamela Sklar, MD, PhD • Albert Siu, MD, MSPH • Barbara G. Vickrey, MD, MPH.
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest integrated delivery system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai's vision is to produce the safest care, the highest quality, the highest satisfaction, the best access and the best value of any health system in the nation. The Health System includes approximately 7,480 primary and specialty care physicians; 11 joint-venture ambulatory surgery centers; more than 410 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools", aligned with a U.S. News & World Report's "Honor Roll" Hospital, No. 12 in the nation for National Institutes of Health funding, and among the top 10 most innovative research institutions as ranked by the journal Nature in its Nature Innovation Index. This reflects a special level of excellence in education, clinical practice, and research. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of top U.S. hospitals; it is one of the nation's top 20 hospitals in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Geriatrics, Gynecology, Nephrology, Neurology/Neurosurgery, and Orthopedics in the 2019-2020 "Best Hospitals" issue. Mount Sinai's Kravis Children's Hospital also is ranked nationally in five out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 12th nationally for Ophthalmology, Mount Sinai St. Lukes and Mount Sinai West are ranked 23rd nationally for Nephrology and 25th for Diabetes/Endocrinology, and Mount Sinai South Nassau is ranked 35th nationally for Urology. Mount Sinai Beth Israel, Mount Sinai St. Luke's, Mount Sinai West, and Mount Sinai South Nassau are ranked regionally.